PureTech Health plc (PRTC)
NASDAQ: PRTC · Real-Time Price · USD
17.42
-0.04 (-0.23%)
Feb 11, 2026, 4:00 PM EST - Market closed
PureTech Health Market Cap
PureTech Health has a market cap or net worth of $425.38 million as of February 12, 2026. Its market cap has decreased by -4.08% in one year.
Market Cap
425.38M
Enterprise Value
251.44M
1-Year Change
-4.08%
Ranking
Category
Stock Price
$17.42
Market Cap Chart
Since June 19, 2015, PureTech Health's market cap has decreased from $642.12M to $425.38M, a decrease of -33.75%. That is a compound annual growth rate of -3.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 425.38M | 4.62% |
| Dec 31, 2025 | 406.60M | -9.69% |
| Dec 31, 2024 | 450.21M | -33.05% |
| Dec 29, 2023 | 672.47M | -24.82% |
| Dec 30, 2022 | 894.49M | -21.39% |
| Dec 31, 2021 | 1.14B | -27.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assembly Biosciences | 425.48M |
| Eupraxia Pharmaceuticals | 425.41M |
| Invivyd | 417.34M |
| Absci | 415.03M |
| Greenwich LifeSciences | 411.90M |
| Niagen Bioscience | 408.45M |
| Neumora Therapeutics | 406.15M |
| Lineage Cell Therapeutics | 404.69M |